Cite
APA Citation
Jacquemin, M., Toelen, J., Schoeters, J., van Horenbeeck, I., Vanlinthout, I., Debasse, M., Peetermans, M., Vanassche, T., Peerlinck, K., van Ryn, J., & Verhamme, P. (n.d.). the addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders. Journal of thrombosis and haemostasis, 13, 2087–2092. http://access.bl.uk/ark:/81055/vdc_100027755730.0x00002a